^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
IBI110
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Innovent Biologics
Drug class:
LAG-3 inhibitor
Related drugs:
Phase 1
Fudan University
Active, not recruiting
Last update posted :
07/10/2024
Initiation :
06/26/2024
Primary completion :
12/31/2026
Completion :
12/31/2028
TMB
|
paclitaxel • Tyvyt (sintilimab) • IBI110
Share
